A team of researchers from Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine) and Tsinghua ...

Moreover, innovations in LNP formulations have improved not only their targeting ability, but also their drug-loading ...

BERLIN--(BUSINESS WIRE)--Bayer AG is joining forces with Acuitas Therapeutics, Inc., a biotechnology company specializing in the development of lipid nanoparticle (LNP) delivery systems for molecular ...

Michael Mitchell, an associate professor of bioengineering at the University, is developing novel lipid nanoparticles that can deliver mRNA inside human cells, which could pave the way for therapies ...

Certest Pharma specializes in advanced lipid nanoparticle technology, focusing on the development of effective and targeted LNPs for next-generation medicines. Certest’s licensable technology includes ...

Researchers from NUS Medicine have developed a novel RNA-based therapy that could transform treatment for metabolic dysfunction-associated steatohepatitis (MASH), previously known as Non-alcoholic ...

CHARLOTTETOWN, Prince Edward Island & VANCOUVER, British Columbia--(BUSINESS WIRE)--BIOVECTRA and Acuitas Therapeutics, Inc. today announced that they have entered into a technology transfer service ...

As the U.S. pulls the funding rug out from under African countries fighting infectious diseases, it is more necessary than ...